Legal Representation
Attorney
Brian Krumm TMCP-UTN
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 16, 2025 | GAUN | O | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | Loading... |
| Dec 16, 2025 | GAUD | O | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | Loading... |
| Dec 16, 2025 | NAUD | R | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | Loading... |
| Dec 2, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 2, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 2, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 26, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 26, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 26, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 12, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 10, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 10, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 2, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 2, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Association services, namely, promoting the public interest and awareness in cancer research and education; Promoting public interest and awareness of cancer research
First Use Anywhere:
Aug 15, 2015
First Use in Commerce:
Aug 15, 2015
Class 042
Providing information about medical research in the field of cancer
First Use Anywhere:
Aug 15, 2015
First Use in Commerce:
Aug 15, 2015
Additional Information
Design Mark
The mark consists of The mark consists of the stylized wording "CGC" wherein the letters are concentrically placed within each other. To the right is stylized wording "CANCER GENOMICS CONSORTIUM".
Classification
International Classes
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
Cancer Genomics Consortium